Purchase Order 75N91023P00799
Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for maintenance agreement services. Qiagen, LLC is a division of Qiagen N.V., a global life sciences company, and will perform the services at its location in Bethesda, Maryland between August 2023 and August 2024 under firm fixed pricing. The award provides support for an existing Qiagen product or solution under a one-year period of performance...
- Qiagen, LLC was awarded a firm fixed price purchase order valued at approximately $723,300 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. Under this contract, Qiagen will provide clinical interpretation of genomic variants from large next-generation panel testing, whole exome sequencing, and whole transcriptome sequencing. Performance will take place in Germantown, Maryland over a two year period concluding...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and...
- This $467,900 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract calls for Qiagen to provide clinical interpretation services for genomic variants identified through large next-generation gene panels, whole exome sequencing, and whole transcriptome sequencing conducted as part of NCI's Clinical Oncologic Molecular Pathology...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,433 firm fixed price purchase order to Qiagen, LLC for unspecified products or services. Qiagen, a subsidiary of Qiagen N.V., will perform the contract from its location in Bethesda, Maryland over a one year period ending August 2024. No additional details were provided regarding the original solicitation or scope of work. However, based on the funding agency, the products or services are...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $30,468 firm fixed price purchase order to Qiagen, LLC. Qiagen will provide products and services to NIH under the contract, which runs from August 2023 through August 2024. Qiagen is a subsidiary of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. The place of performance is...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for a maintenance agreement valued at $13,967.00. The contract has an ultimate completion date of August 31, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has provided a range of...
- Qiagen, LLC received a Blanket Purchase Agreement (BPA) call contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health, valued at $24,632.58. The contract, awarded on July 6, 2017, with an ultimate completion date of July 3, 2018, was issued without set-aside designation, reflecting the contractor's ability to compete in the open federal marketplace. The award utilized fixed-price pricing with economic price adjustment terms and represents a call...